Fast Facts

ZIMBABWE continues to record positive strides in the fight against the deadly Tuberculosis disease with the estimated incidence rate going down from 242 per 100 000 in 2015 to 204 per 100 000 in 2022. While the country has made progress, TB remains a leading cause of death and there are still many challenges.

Challenges

Missed cases: Many people with TB go undiagnosed and untreated.

Drug-resistant TB: There is a significant burden of drug-resistant TB.

High out-of-pocket costs: Many TB patients face high costs for treatment.

Limited diagnostic capacity: There are few facilities that can conduct TB sputum culture microscopy.

Stigma and discrimination: People with TB may face stigma and discrimination.

Poverty: Poverty can make it difficult for people to access health services.

Progress

Zimbabwe has made progress in reducing the TB burden.

It launched the Multi-Sectoral Accountability Framework for TB (MAF-TB) to increase efforts to end TB.

Zimbabwe has free TB diagnosis at national laboratories.

Treatment

In 2020, the TB treatment success rate in Zimbabwe was 88%.

TB is the second leading cause of death in Zimbabwe.

To ensure that TB services are brought close to where people live, the Ministry of Health and Child Care has been implementing targeted screening for active TB (TaS4TB) to detect missed TB cases amongst high-risk and hard-to-reach populations in Zimbabwe since 2014.

Related Posts

Government urges communities to confront the realities of climate change

  Muchaneta Chimuka THE Good Seed and Food Festival has roared to life with several farmers exhibiting indigenous seeds, live music, Gule dance, cooking experiences, inspiring people and reminding them…

Nguluvhe reaches out to 2,077 Grade Seven candidates in Beitbridge East

  Thupeyo Muleya Beitbridge Bureau Beitbridge East Member of Parliament, who is also the Matabeleland South Provincial Affairs and Devolution Minister, Albert Nguluvhe, has extended support to all Grade Seven…

Leave a Reply

Your email address will not be published. Required fields are marked *